Neurocognitive Late Effects Among Childhood Cancer Survivors: A Holistic Review of Clinical Risk Factors.
AI interpretation is pending for this paper.
Open original publication →What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
Childhood cancer survivors are at risk for neurocognitive deficits because of the past treatment received and, if involving the central nervous system, the malignancy itself. It is vital to maintain a holistic perspective in caring for childhood cancer survivors to identify and address the multiple factors associated with neurocognitive outcomes in this patient population in addition to the cancer and treatment received. In this review, we provide an overview of the many factors of a cancer experience that can impact neurocognition and discuss opportunities for clinician screening.